2021 market access prospects for Germany
pharmaphorum
FEBRUARY 23, 2021
IQWiG sees far less promise in other RWE sources such as electronic medical records and billing records of insurers. Such deals are not national but can be agreed at the insurer level. Any changes to AMNOG will likely be a worry to industry as there has already been a toughening in AMNOG assessments since 2011.”.
Let's personalize your content